← Back to all trials
Recruiting
NCT06479616
A Long-term Follow-up Study in Participants Who Received CS-101
Conditions: Beta-Thalassemia
Sex: All
Ages: 3 Years – 17 Years
Healthy volunteers: No
Phase: NA
Enrollment: 5
Sponsor: Children's Hospital of Fudan University
Location: Children's Hospital of Fudan University Shanghai Shanghai Municipality
Summary
This is a study to evaluate the long-term safety and efficacy of CS-101 in participants who received CS-101 in study CS -101-03 (NCT06065189)
Eligibility Criteria
Inclusion Criteria:
* Participants (or his or her legally appointed and authorized representative or guardian) must sign and date informed consent form (ICF) and, where applicable, an assent form
* Participants must have received CS-101 infusion in last IIT study
Exclusion Criteria:
* There are no exclusion criteria
Source: ClinicalTrials.gov (NCT06479616). StuddyBuddy aggregates publicly available trial information.
